Skip to main content
AAN.com

Abstract

For Parkinson's disease (PD), little is known about how the choice of diagnostic criteria affects research results. Using data on PD from three community studies (from Argentina, the Netherlands, Italy), we compared the impact on prevalence of several sets of diagnostic criteria. Each set was based on cardinal signs—resting tremor, bradykinesia, rigidity, impaired postural reflexes—and required that other parkinsonism be excluded. Some sets had additional requirements related to duration of symptoms, asymmetry of signs, or response to medication. In terms of prevalence, much lower estimates were associated with the requirements of asymmetry of signs and response to medication. The assessment of these clinical features may not be practical in community studies. Impaired postural reflexes, as a cardinal sign, seemed superfluous. For community studies of PD, we recommend the following diagnostic criteria: at least two of resting tremor, bradykinesia, or rigidity, in the absence of other apparent causes of parkinsonism.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 48Number 5May 1997
Pages: 1277-1281
PubMed: 9153457

Publication History

Published online: May 1, 1997
Published in print: May 1997

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

M. C. de Rijk, MD
From the Department of Epidemiology & Biostatistics (Drs. de Rijk and Breteler), the Department of Neurology (Dr. de Rijk), and the Erasmus Center for Research on Aging (Dr. de Rijk), Erasmus University Medical School, Rotterdam, the Netherlands; the Departments of Health Sciences Research (Dr. Rocca) and Neurology (Drs. Rocca and Maraganore), Mayo Clinic and Mayo Foundation, Rochester, MN; the Biometry and Field Studies Branch (Dr. Anderson), National Institute of Neurological Disorders and Stroke, Bethesda, MD; and the Department of Neurology (Dr. Melcon), Regional Hospital, Junin, Buenos Ares Province, Argentina.
W. A. Rocca, MD, MPH
From the Department of Epidemiology & Biostatistics (Drs. de Rijk and Breteler), the Department of Neurology (Dr. de Rijk), and the Erasmus Center for Research on Aging (Dr. de Rijk), Erasmus University Medical School, Rotterdam, the Netherlands; the Departments of Health Sciences Research (Dr. Rocca) and Neurology (Drs. Rocca and Maraganore), Mayo Clinic and Mayo Foundation, Rochester, MN; the Biometry and Field Studies Branch (Dr. Anderson), National Institute of Neurological Disorders and Stroke, Bethesda, MD; and the Department of Neurology (Dr. Melcon), Regional Hospital, Junin, Buenos Ares Province, Argentina.
D. W. Anderson, PhD
From the Department of Epidemiology & Biostatistics (Drs. de Rijk and Breteler), the Department of Neurology (Dr. de Rijk), and the Erasmus Center for Research on Aging (Dr. de Rijk), Erasmus University Medical School, Rotterdam, the Netherlands; the Departments of Health Sciences Research (Dr. Rocca) and Neurology (Drs. Rocca and Maraganore), Mayo Clinic and Mayo Foundation, Rochester, MN; the Biometry and Field Studies Branch (Dr. Anderson), National Institute of Neurological Disorders and Stroke, Bethesda, MD; and the Department of Neurology (Dr. Melcon), Regional Hospital, Junin, Buenos Ares Province, Argentina.
M. O. Melcon, MD
From the Department of Epidemiology & Biostatistics (Drs. de Rijk and Breteler), the Department of Neurology (Dr. de Rijk), and the Erasmus Center for Research on Aging (Dr. de Rijk), Erasmus University Medical School, Rotterdam, the Netherlands; the Departments of Health Sciences Research (Dr. Rocca) and Neurology (Drs. Rocca and Maraganore), Mayo Clinic and Mayo Foundation, Rochester, MN; the Biometry and Field Studies Branch (Dr. Anderson), National Institute of Neurological Disorders and Stroke, Bethesda, MD; and the Department of Neurology (Dr. Melcon), Regional Hospital, Junin, Buenos Ares Province, Argentina.
M.M.B. Breteler, MD, PhD
From the Department of Epidemiology & Biostatistics (Drs. de Rijk and Breteler), the Department of Neurology (Dr. de Rijk), and the Erasmus Center for Research on Aging (Dr. de Rijk), Erasmus University Medical School, Rotterdam, the Netherlands; the Departments of Health Sciences Research (Dr. Rocca) and Neurology (Drs. Rocca and Maraganore), Mayo Clinic and Mayo Foundation, Rochester, MN; the Biometry and Field Studies Branch (Dr. Anderson), National Institute of Neurological Disorders and Stroke, Bethesda, MD; and the Department of Neurology (Dr. Melcon), Regional Hospital, Junin, Buenos Ares Province, Argentina.
D. M. Maraganore, MD
From the Department of Epidemiology & Biostatistics (Drs. de Rijk and Breteler), the Department of Neurology (Dr. de Rijk), and the Erasmus Center for Research on Aging (Dr. de Rijk), Erasmus University Medical School, Rotterdam, the Netherlands; the Departments of Health Sciences Research (Dr. Rocca) and Neurology (Drs. Rocca and Maraganore), Mayo Clinic and Mayo Foundation, Rochester, MN; the Biometry and Field Studies Branch (Dr. Anderson), National Institute of Neurological Disorders and Stroke, Bethesda, MD; and the Department of Neurology (Dr. Melcon), Regional Hospital, Junin, Buenos Ares Province, Argentina.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Behind the Mask: Parkinson's Disease and Depression, Cureus, (2024).https://doi.org/10.7759/cureus.52663
    Crossref
  2. The Analysis of relation to brain iron deposition of Parkinson’s Disease using Quantitative Susceptibility Mapping, Journal of Korean Medicine, 45, 1, (148-162), (2024).https://doi.org/10.13048/jkm.24010
    Crossref
  3. A systematic review and meta-analysis of the prevalence of Parkinson’s disease in lower to upper-middle-income countries, npj Parkinson's Disease, 10, 1, (2024).https://doi.org/10.1038/s41531-024-00779-y
    Crossref
  4. Global prevalence and incidence of Young Onset Parkinson’s disease: A systematic review and meta-analysis, Journal of Clinical Neuroscience, 125, (59-67), (2024).https://doi.org/10.1016/j.jocn.2024.05.015
    Crossref
  5. Neuroprotection by tetramethylpyrazine and its synthesized analogues for central nervous system diseases: a review, Molecular Biology Reports, 51, 1, (2024).https://doi.org/10.1007/s11033-023-09068-y
    Crossref
  6. Cross‐Sectional and Prospective Associations between Parkinsonism and Parkinson's Disease with Frailty in Latin America, Movement Disorders Clinical Practice, (2024).https://doi.org/10.1002/mdc3.14214
    Crossref
  7. Fluphenazine-Induced Neurotoxicity with Acute Almost Transient Parkinsonism and Permanent Memory Loss: Lessons from a Case Report, International Journal of Molecular Sciences, 24, 3, (2968), (2023).https://doi.org/10.3390/ijms24032968
    Crossref
  8. Frequency, pattern and predictors of cognitive impairments in patients with Parkinson’s disease using the Community Screening Instrument for Dementia, Frontiers in Human Neuroscience, 17, (2023).https://doi.org/10.3389/fnhum.2023.1126526
    Crossref
  9. High clinical diagnostic accuracy of combined salivary gland and myocardial metaiodobenzylguanidine scintigraphy in the diagnosis of Parkinson’s disease, Frontiers in Aging Neuroscience, 14, (2023).https://doi.org/10.3389/fnagi.2022.1066331
    Crossref
  10. Burden of Parkinsonism and Parkinson’s Disease on Health Service Use and Outcomes in Latin America, Journal of Parkinson's Disease, 13, 7, (1199-1211), (2023).https://doi.org/10.3233/JPD-230114
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share